KEAP1 - kelch like ECH associated protein 1 Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102118980
KEAP1 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| XM_045381082.1 | XP_045237017.1 | kelch-like ECH-associated protein 1 |
| XM_045381080.1 | XP_045237015.1 | kelch-like ECH-associated protein 1 |
| XM_045381081.1 | XP_045237016.1 | kelch-like ECH-associated protein 1 |
| XM_045381079.1 | XP_045237014.1 | kelch-like ECH-associated protein 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
kelch-like ECH-associated protein 1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-W012382 | N-Acetyl-L-tyrosine | 99.48% | Unkown |
Clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-N0005 | Curcumin | 98.84% | Phase 4 | |
| HY-13755 | Sulforaphane | 99.75% | Phase 4 | |
| HY-159641 | VVD-130037 | Activator | 99.91% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(125)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-100218A | RSL3 | 99.87% | Unkown | |
| HY-112675 | 4-Octyl itaconate | Activator | 99.92% | Unkown |
| HY-19543 | Brusatol | 99.94% | Unkown | |
| HY-101140 | KI696 | Inhibitor | 99.26% | Unkown |
| HY-110258 | ML334 | Activator | 99.76% | Unkown |
| HY-134205A | CBR-470-1 | Activator | 98.02% | Unkown |
| HY-113298 | Citraconic acid | Inhibitor | 99.08% | Unkown |
| HY-N0147 | Rutaecarpine | 99.77% | Unkown | |
| HY-N0005R | Curcumin (Standard) | 98.01% | Unkown | |
| HY-N0806 | Sweroside | 99.76% | Unkown | |
| HY-P2048 | MOTS-c (human) | 99.90% | Unkown | |
| HY-13755A | (R)-Sulforaphane | 99.95% | Unkown | |
| HY-P2048A | MOTS-c(human) acetate | Activator | 99.74% | Unkown |
| HY-N0353 | Curdione | Inhibitor | 99.80% | Unkown |
| HY-N1437 | Hydroxycitric acid | 99.95% | Unkown | |
| HY-111126 | K67 | Inhibitor | 98.26% | Unkown |
| HY-N0493 | Pectolinarigenin | 99.98% | Unkown | |
| HY-113162 | Bovinic acid | ≥99.0% | Unkown | |
| HY-149508 | Nrf2-IN-3 | 98.10% | Unkown | |
| HY-120371 | CPUY192018 | Inhibitor | 98.90% | Unkown |
| HY-145879 | Nrf2 activator-2 | Activator | 99.20% | Unkown |
| HY-W009731 | Dibenzoylmethane | Activator | 98.0% | Unkown |
| HY-153873 | MSU38225 | 99.94% | Unkown | |
| HY-N0260 | Epmedin C | 99.47% | Unkown | |
| HY-110275 | RA839 | Inhibitor | 98.54% | Unkown |
| HY-103435 | Vialinin A | 99.90% | Unkown | |
| HY-131592 | Tricetin | 99.88% | Unkown | |
| HY-B0854 | Mancozeb | 85.50% | Unkown | |
| HY-N0005S | Curcumin-d6 | 99.78% | Unkown | |
| HY-N0008 | Orcinol glucoside | 99.40% | Unkown | |
| HY-101140A | KI696 isomer | Inhibitor | 98.44% | Unkown |
| HY-171705 | KMS99220 | 99.48% | Unkown | |
| HY-W338584 | Hydroxycitric acid tripotassium | 98.0% | Unkown | |
| HY-100218C | (1R,3R)-RSL3 | Control | 99.05% | Unkown |
| HY-139047 | SW157765 | Inhibitor | 98.08% | Unkown |
| HY-149010 | NXPZ-2 | Inhibitor | 98.55% | Unkown |
| HY-151362 | Keap1-Nrf2-IN-14 | Inhibitor | 98.08% | Unkown |
| HY-169766 | VVD 065 | Degrader | 99.71% | Unkown |
| HY-160876 | BC-1901S | Activator | 99.81% | Unkown |
| HY-P1328 | TAT-14 | Activator | 99.71% | Unkown |
| HY-162152 | biKEAP1 | Inhibitor | 99.44% | Unkown |
| HY-110258B | (R,S,R)-ML334 | Control | 98.57% | Unkown |
| HY-P10530 | Nrf2 (69-84) | 95.25% | Unkown | |
| HY-W012382S | N-Acetyl-L-tyrosine-d3 | 98.44% | Unkown | |
| HY-W017187 | 2-tert-Butyl-1,4-benzoquinone | 99.34% | Unkown | |
| HY-147517 | Keap1-Nrf2-IN-9 | Inhibitor | 98.52% | Unkown |
| HY-121523 | MIND4-17 | Activator | 99.05% | Unkown |
| HY-150579 | Keap1-Nrf2-IN-13 | Inhibitor | 96.77% | Unkown |
| HY-173444 | HDAC11-IN-3 | 99.70% | Unkown | |
| HY-124834 | Nrf2 activator-10 | 98.65% | Unkown | |
| HY-146577 | Keap1-Nrf2-IN-7 | Inhibitor | 99.82% | Unkown |
| HY-P5909 | Keap1-Nrf2 probe | 98.75% | Unkown | |
| HY-P5909F | FITC-labeled Keap1-Nrf2 probe | 98.57% | Unkown | |
| HY-RS07231 | Keap1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-122054 | BPK-29 | 99.4% | Unkown | |
| HY-122054A | BPK-29 hydrochloride | Inhibitor | 99.19% | Unkown |
| HY-178054 | LMDP10 | Activator | 99.91% | Unkown |
| HY-139620 | MS83 | / | Unkown | |
| HY-139620A | MS83 epimer 1 | 98.36% | Unkown | |
| HY-113510 | 9(S)-HOTrE | 99.9% | Unkown | |
| HY-N8160 | Dehydrocurdione | 97% | Unkown | |
| HY-RS07230 | KEAP1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-112675R | 4-Octyl itaconate (Standard) | Activator | / | Unkown |
| HY-124941 | 7-Deacetylgedunin | Activator | / | Unkown |
| HY-139862 | Keap1-Nrf2-IN-3 | Inhibitor | / | Unkown |
| HY-141439 | TBE 31 | / | Unkown | |
| HY-143892 | Keap1-Nrf2-IN-5 | Inhibitor | / | Unkown |
| HY-143893 | Keap1-Nrf2-IN-6 | Inhibitor | / | Unkown |
| HY-144099 | Keap1-Nrf2-IN-4 | / | Unkown | |
| HY-146578 | Keap1-Nrf2-IN-8 | Inhibitor | / | Unkown |
| HY-147924 | Keap1-Nrf2-IN-11 | Inhibitor | / | Unkown |
| HY-149245 | Keap1-Nrf2-IN-15 | Inhibitor | / | Unkown |
| HY-150578 | Keap1-Nrf2-IN-12 | Inhibitor | / | Unkown |
| HY-155997 | Anti-inflammatory agent 56 | Inhibitor | / | Unkown |
| HY-156065 | S217879 | / | Unkown | |
| HY-157928 | Keap1-Nrf2-IN-18 | Inhibitor | / | Unkown |
| HY-157929 | Keap1-Nrf2-IN-19 | Inhibitor | / | Unkown |
| HY-159495 | Keap1-Nrf2-IN-21 | / | Unkown | |
| HY-161643 | S21-1011 | / | Unkown | |
| HY-168065 | Keap1-Nrf2-IN-22 | Inhibitor | / | Unkown |
| HY-168161 | Keap1-Nrf2-IN-23 | Inhibitor | / | Unkown |
| HY-168526 | Keap1-Nrf2-IN-24 | Inhibitor | / | Unkown |
| HY-168640 | RIP3 activator 1 | / | Unkown | |
| HY-168709 | Nrf2 activator 18 | Activator | / | Unkown |
| HY-168922 | Keap1-Nrf2-IN-25 | Inhibitor | / | Unkown |
| HY-169315 | Nrf2 activator 17 | Activator | / | Unkown |
| HY-170301 | Keap1-IN-1 | Inhibitor | / | Unkown |
| HY-170761 | KEAP1-NRF2 PPI-IN-1 | Inhibitor | / | Unkown |
| HY-171035 | PRL-295 | Inhibitor | / | Unkown |
| HY-172598 | SG16 | Inhibitor | / | Unkown |
| HY-173039 | α-Tubulin polymerization-IN-1 | / | Unkown | |
| HY-173181 | Anticonvulsant agent 10 | Inhibitor | / | Unkown |
| HY-173187 | Keap1-Nrf2-IN-27 | Inhibitor | / | Unkown |
| HY-174395 | CD-10 | / | Unkown | |
| HY-175217 | Nrf2 activator-20 | Activator | / | Unkown |
| HY-175548 | Nrf2 activator-21 | / | Unkown | |
| HY-175833 | NF-κB-IN-20 | / | Unkown | |
| HY-176146 | Keap1/Nrf2/ARE activator 1 | Activator | / | Unkown |
| HY-178873 | PROTAC K-Ras Degrader-7 | Degrader | / | Unkown |
| HY-179398 | Keap1-Nrf2-IN-29 | Inhibitor | / | Unkown |
| HY-180112 | SH543 | / | Unkown | |
| HY-180155 | Keap1/Nrf2/ARE activator 2 | / | Unkown | |
| HY-181818 | 4,5-Dehydro-6-oxoallosecurinine | / | Unkown | |
| HY-181887 | Nrf2 activator-23 | / | Unkown | |
| HY-181907 | NBE5 | / | Unkown | |
| HY-181908 | 5-Norbornene-2-methylamine-C10-NH2 | / | Unkown | |
| HY-183353 | Nrf2 activator-25 | / | Unkown | |
| HY-184204 | Keap1-p-p62-IN-1 | / | Unkown | |
| HY-N10313 | Dehydrobruceine B | / | Unkown | |
| HY-N17317 | Isostrictiniin | / | Unkown | |
| HY-N17603 | Ginnalin A | Activator | / | Unkown |
| HY-N19738 | Obtusaquinone | / | Unkown | |
| HY-P1328A | TAT-14 TFA | Activator | / | Unkown |
| HY-P5480 | Keap1-Nrf2-IN-16 | / | Unkown | |
| HY-RS07232 | Keap1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W701218 | Sulforaphane-d8 | / | Unkown | |
| HY-112675S | 4-Octyl itaconate-13C5-1 | / | Unkown | |
| HY-147548 | Keap1-Nrf2-IN-10 | Inhibitor | / | Unkown |
| HY-162096 | Keap1-Nrf2-IN-17 | Inhibitor | / | Unkown |
| HY-174287 | Keap1-IN-2 | Inhibitor | / | Unkown |
| HY-182927 | KLHL12 ligand-1 | / | Unkown | |
| HY-183448 | ETMTC | / | Unkown | |
| HY-N0005S1 | Curcumin-d3 | / | Unkown | |
| HY-N0493R | Pectolinarigenin (Standard) | / | Unkown | |
| HY-W505984 | TPNA10168 | Activator | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service